Nuclear Medicine
MAA
Name:
Albumin Macroagregate
Active Principle:
Human Albumin Macroagregate
Therapeutic Action:
It is indicated for lung imaging by scintigraphy. It is used for:
– Assessment of pulmonary perfusion for the diagnosis or exclusion of pulmonary embolism
– Assessment of peritoneal-venous (LeVeen) shunt patency.
– Simultaneous explorations with treatments that result in a significant reduction in regional pulmonary perfusion.
– Preoperative studies of local pulmonary perfusion prior to a partial lung resection in a preoperative exploration.
– Monitoring the progress of lung transplants, as well as complementary pre-therapeutic examinations for radiotherapy planning. – Initial evaluation and follow-up of patients suffering from severe obstructive and/or restrictive lung diseases in combination with a ventilation scan.
– Diagnosis and quantification of right-to-left pulmonary shunts. It is also used as an alternative to Doppler ultrasound for lower extremity Phleboscintigraphy, in combination with pulmonary perfusion scintigraphy for patients suspected of having deep lower extremity phlebothrombosis and pulmonary embolism (venography). isotopic).
Nuclear Medicine
MAA
Name:
Albumin Macroagregate
Active Principle:
Human Albumin Macroagregate
Therapeutic Action:
It is indicated for lung imaging by scintigraphy. It is used for:
– Assessment of pulmonary perfusion for the diagnosis or exclusion of pulmonary embolism
– Assessment of peritoneal-venous (LeVeen) shunt patency.
– Simultaneous explorations with treatments that result in a significant reduction in regional pulmonary perfusion.
– Preoperative studies of local pulmonary perfusion prior to a partial lung resection in a preoperative exploration.
– Monitoring the progress of lung transplants, as well as complementary pre-therapeutic examinations for radiotherapy planning. – Initial evaluation and follow-up of patients suffering from severe obstructive and/or restrictive lung diseases in combination with a ventilation scan.
– Diagnosis and quantification of right-to-left pulmonary shunts. It is also used as an alternative to Doppler ultrasound for lower extremity Phleboscintigraphy, in combination with pulmonary perfusion scintigraphy for patients suspected of having deep lower extremity phlebothrombosis and pulmonary embolism (venography). isotopic).
RELATED PRODUCTS
-
PSMA (R+D)
PSMA (R+D)It is indicated for the detection and evaluation of prostate cancer from the initial diagnosis to the monitoring of castration-resistant metastases. -
FLPET (R+D)
FLPET (R+D)It is indicated for the detection and evaluation of cell proliferation in lung, breast, colorectal, melanoma, soft tissue sarcoma and primary or metastatic brain tumors. It allows to predict the aggressiveness... -
IODOSOL 123I (R&D)
IODOSOL 123I (R&D)Sodium iodide (123I) solution is indicated as a diagnostic agent to evaluate thyroid function and/or morphology by scintigraphy and radioactive iodine uptake test.